Clindamycin Phosphate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Clindamycin Phosphate Injection (injection) from Baxter Healthcare with status Current. The shortage was first posted on 03/21/2023. Reported reason: Demand increase for the drug
Shortage Details
- Status
- Current
- Company
- Baxter Healthcare
- Package NDC
- 0338-9549-50
- Dosage Form
- Injection
- Presentation
- Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50)
- Initial Posting
- 03/21/2023
- Revised Date
Reason
Demand increase for the drug